Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)

NCT00899431 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Stopped Terminated per PI's request at the time of continuing review

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Lenalidomide
DRUG: Fludarabine
DRUG: Rituximab
DRUG: Thymoglobulin
PROCEDURE: Stem Cell Transplantation
DRUG: Bendamustine
DRUG: Allopurinol

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]